Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2011, Volume 70, Issue 3, pp. 434 - 439
Objective To determine the sensitivity and specificity of enthesis ultrasound for the diagnostic classification of early spondyloarthritis. Methods A...
SPONDYLARTHRITIS | MULTICENTER | DOUBLE-BLIND | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | SPINAL INFLAMMATION | ULTRASONOGRAPHY | INFLIXIMAB | CLASSIFICATION CRITERIA | ACTIVE ANKYLOSING-SPONDYLITIS | POWER DOPPLER | Diagnosis, Differential | Patellar Ligament - diagnostic imaging | Spondylarthritis - diagnostic imaging | Humans | Middle Aged | Male | Achilles Tendon - diagnostic imaging | Ultrasonography, Doppler - methods | Epidemiologic Methods | Tendons - diagnostic imaging | Adult | Female | Early Diagnosis | Usage | Diagnosis, Ultrasonic | Analysis | Spondyloarthropathies | Physiological aspects | Diagnosis | Research | Tendons
SPONDYLARTHRITIS | MULTICENTER | DOUBLE-BLIND | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | SPINAL INFLAMMATION | ULTRASONOGRAPHY | INFLIXIMAB | CLASSIFICATION CRITERIA | ACTIVE ANKYLOSING-SPONDYLITIS | POWER DOPPLER | Diagnosis, Differential | Patellar Ligament - diagnostic imaging | Spondylarthritis - diagnostic imaging | Humans | Middle Aged | Male | Achilles Tendon - diagnostic imaging | Ultrasonography, Doppler - methods | Epidemiologic Methods | Tendons - diagnostic imaging | Adult | Female | Early Diagnosis | Usage | Diagnosis, Ultrasonic | Analysis | Spondyloarthropathies | Physiological aspects | Diagnosis | Research | Tendons
Journal Article
Rheumatology International, ISSN 0172-8172, 7/2014, Volume 34, Issue 7, pp. 953 - 961
Data on infections in patients exposed to biologic therapies are mainly focused on rheumatoid arthritis (RA). Little is known about the safety profile in other...
Serious infections | Medicine & Public Health | Immune-mediated connective tissue diseases | Rheumatoid arthritis | Rheumatology | Anti-TNF | Rituximab | MORTALITY | RATES | RISK-FACTORS | THERAPY | SAFETY | RHEUMATOLOGY | Virus Diseases - epidemiology | Connective Tissue Diseases - epidemiology | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Virus Diseases - complications | Arthritis, Rheumatoid - complications | Incidence | Bacterial Infections - complications | Arthritis, Rheumatoid - drug therapy | Registries - statistics & numerical data | Antirheumatic Agents - adverse effects | Adult | Female | Opportunistic Infections - complications | Opportunistic Infections - epidemiology | Comorbidity | Risk Factors | Arthritis, Rheumatoid - epidemiology | Connective Tissue Diseases - drug therapy | Bacterial Infections - epidemiology | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Connective Tissue Diseases - complications | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antimitotic agents | Rheumatoid factor | Care and treatment | Tumor necrosis factor | Analysis | Mortality | Resveratrol | Arthritis | Antineoplastic agents | Health aspects
Serious infections | Medicine & Public Health | Immune-mediated connective tissue diseases | Rheumatoid arthritis | Rheumatology | Anti-TNF | Rituximab | MORTALITY | RATES | RISK-FACTORS | THERAPY | SAFETY | RHEUMATOLOGY | Virus Diseases - epidemiology | Connective Tissue Diseases - epidemiology | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Virus Diseases - complications | Arthritis, Rheumatoid - complications | Incidence | Bacterial Infections - complications | Arthritis, Rheumatoid - drug therapy | Registries - statistics & numerical data | Antirheumatic Agents - adverse effects | Adult | Female | Opportunistic Infections - complications | Opportunistic Infections - epidemiology | Comorbidity | Risk Factors | Arthritis, Rheumatoid - epidemiology | Connective Tissue Diseases - drug therapy | Bacterial Infections - epidemiology | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Connective Tissue Diseases - complications | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antimitotic agents | Rheumatoid factor | Care and treatment | Tumor necrosis factor | Analysis | Mortality | Resveratrol | Arthritis | Antineoplastic agents | Health aspects
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e40620
Introduction: The purpose of this study was to examine the role of RA Synovial Fibroblast (RASFib) IL-15 expression on B cell survival. Methods: Magnetically...
BETA-CHAIN | NECROSIS-FACTOR | MULTIDISCIPLINARY SCIENCES | DISEASE | FOLLICULAR DENDRITIC CELLS | SYNOVIOCYTES | RECEPTOR | PROLIFERATION | T-CELL | DIFFERENTIATION | RHEUMATOID-ARTHRITIS PATIENTS | Cell Survival - drug effects | Coculture Techniques | Humans | Middle Aged | Synovial Membrane - immunology | Male | Receptors, Interleukin-15 - metabolism | Synovial Membrane - metabolism | Arthritis, Rheumatoid - metabolism | B-Lymphocytes - drug effects | Interleukin-15 - pharmacology | B-Cell Activating Factor - metabolism | B-Lymphocytes - immunology | Interleukin-15 - metabolism | Aged, 80 and over | Female | Immunologic Memory | Aged | Arthritis, Rheumatoid - immunology | Vascular Cell Adhesion Molecule-1 - metabolism | B-Lymphocytes - metabolism | Fibroblasts - metabolism | B cells | Lymphocyte receptors | Cell culture | Memory cells | Vascular cell adhesion molecule 1 | Immunological memory | Cell survival | Chains | T cell receptors | Joint surgery | Interleukin 15 | Survival | Blood | Lymphocytes B | Lymphocytes | BLyS protein | Neutralizing | Peripheral blood | Fibroblasts | Interleukin 15 receptors | Apoptosis
BETA-CHAIN | NECROSIS-FACTOR | MULTIDISCIPLINARY SCIENCES | DISEASE | FOLLICULAR DENDRITIC CELLS | SYNOVIOCYTES | RECEPTOR | PROLIFERATION | T-CELL | DIFFERENTIATION | RHEUMATOID-ARTHRITIS PATIENTS | Cell Survival - drug effects | Coculture Techniques | Humans | Middle Aged | Synovial Membrane - immunology | Male | Receptors, Interleukin-15 - metabolism | Synovial Membrane - metabolism | Arthritis, Rheumatoid - metabolism | B-Lymphocytes - drug effects | Interleukin-15 - pharmacology | B-Cell Activating Factor - metabolism | B-Lymphocytes - immunology | Interleukin-15 - metabolism | Aged, 80 and over | Female | Immunologic Memory | Aged | Arthritis, Rheumatoid - immunology | Vascular Cell Adhesion Molecule-1 - metabolism | B-Lymphocytes - metabolism | Fibroblasts - metabolism | B cells | Lymphocyte receptors | Cell culture | Memory cells | Vascular cell adhesion molecule 1 | Immunological memory | Cell survival | Chains | T cell receptors | Joint surgery | Interleukin 15 | Survival | Blood | Lymphocytes B | Lymphocytes | BLyS protein | Neutralizing | Peripheral blood | Fibroblasts | Interleukin 15 receptors | Apoptosis
Journal Article
Rheumatology International, ISSN 0172-8172, 2/2016, Volume 36, Issue 2, pp. 221 - 229
The aim of the study was to analyze the efficacy and satisfaction of multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe...
Medicine & Public Health | Psoriasis | Rheumatology | Systematic review | Management | Consultations | Multidisciplinary | Psoriatic arthritis | SYMPTOMS | PREVALENCE | RHEUMATOLOGY | MODULAR APPROACH | DISEASE | UVEITIS | EXPERIENCE | SCREENING QUESTIONNAIRE | EPIDEMIOLOGY | Severity of Illness Index | Dermatology | Humans | Psoriasis - diagnosis | Patient Care Team | Arthritis, Psoriatic - diagnosis | Treatment Outcome | Remission Induction | Patient Satisfaction | Interdisciplinary Communication | Time Factors | Waiting Lists | Referral and Consultation | Arthritis, Psoriatic - therapy | Psoriasis - therapy | Care and treatment | Analysis
Medicine & Public Health | Psoriasis | Rheumatology | Systematic review | Management | Consultations | Multidisciplinary | Psoriatic arthritis | SYMPTOMS | PREVALENCE | RHEUMATOLOGY | MODULAR APPROACH | DISEASE | UVEITIS | EXPERIENCE | SCREENING QUESTIONNAIRE | EPIDEMIOLOGY | Severity of Illness Index | Dermatology | Humans | Psoriasis - diagnosis | Patient Care Team | Arthritis, Psoriatic - diagnosis | Treatment Outcome | Remission Induction | Patient Satisfaction | Interdisciplinary Communication | Time Factors | Waiting Lists | Referral and Consultation | Arthritis, Psoriatic - therapy | Psoriasis - therapy | Care and treatment | Analysis
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 08/2019, Volume 22, Issue 8, pp. 1393 - 1401
Background Inflammatory idiopathic myositis (IIM) comprises a heterogeneous group of systemic muscular diseases that can occur together with other connective...
mortality | overlap myositis | polymyositis | dermatomyositis | inflammatory idiopathic myositis | SURVIVAL | PROGNOSTIC-FACTORS | LABORATORY FEATURES | CONNECTIVE-TISSUE DISEASE | CLINICAL-FEATURES | TERM | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | INTERSTITIAL LUNG-DISEASE | Rheumatoid factor | Systemic lupus erythematosus | Systemic scleroderma | Analysis | Mortality | Scleroderma (Disease) | Myositis | Respiratory tract diseases | Arthritis | Health aspects | Thrombocytopenia | Sjogren's syndrome | Muscular diseases | Connective tissue diseases | Lung diseases | Dermatomyositis | Infections | Inflammation | Survival | Patients | Polymyositis | Rheumatoid arthritis | Systemic sclerosis | Medical prognosis | Dysphagia | Mixed connective tissue disease
mortality | overlap myositis | polymyositis | dermatomyositis | inflammatory idiopathic myositis | SURVIVAL | PROGNOSTIC-FACTORS | LABORATORY FEATURES | CONNECTIVE-TISSUE DISEASE | CLINICAL-FEATURES | TERM | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | INTERSTITIAL LUNG-DISEASE | Rheumatoid factor | Systemic lupus erythematosus | Systemic scleroderma | Analysis | Mortality | Scleroderma (Disease) | Myositis | Respiratory tract diseases | Arthritis | Health aspects | Thrombocytopenia | Sjogren's syndrome | Muscular diseases | Connective tissue diseases | Lung diseases | Dermatomyositis | Infections | Inflammation | Survival | Patients | Polymyositis | Rheumatoid arthritis | Systemic sclerosis | Medical prognosis | Dysphagia | Mixed connective tissue disease
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 03/2019, Volume 38, Issue 3, pp. 803 - 815
ObjectiveTo study prognostic factors in different types of idiopathic inflammatory myopathies (IIM) associated with interstitial lung disease (ILD).Patients...
Myositis | Prognosis | Oxygen therapy | Interstitial lung disease | Survival | Respiratory function tests | DERMATOMYOSITIS | PROGNOSTIC-FACTORS | POLYMYOSITIS | SINGLE-CENTER | CONNECTIVE-TISSUE DISEASE | RHEUMATOLOGY | CLINICAL-MANIFESTATIONS | REVISED CRITERIA | COHORT | RETROSPECTIVE ANALYSIS | Medical research | Mortality | Analysis | Lung diseases | Medicine, Experimental | Pulmonary function tests | Health aspects | Respiratory function | Polymyositis | Medical prognosis | Dermatomyositis | Inflammation | Regression analysis | Diagnosis | Multivariate analysis | Erythema
Myositis | Prognosis | Oxygen therapy | Interstitial lung disease | Survival | Respiratory function tests | DERMATOMYOSITIS | PROGNOSTIC-FACTORS | POLYMYOSITIS | SINGLE-CENTER | CONNECTIVE-TISSUE DISEASE | RHEUMATOLOGY | CLINICAL-MANIFESTATIONS | REVISED CRITERIA | COHORT | RETROSPECTIVE ANALYSIS | Medical research | Mortality | Analysis | Lung diseases | Medicine, Experimental | Pulmonary function tests | Health aspects | Respiratory function | Polymyositis | Medical prognosis | Dermatomyositis | Inflammation | Regression analysis | Diagnosis | Multivariate analysis | Erythema
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2014, Volume 44, Issue 2, pp. 175 - 185
Abstract Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus (SLE). Methods We systematically...
Rheumatology | Rituximab | Systematic review | Systemic lupus erythematosus | CYCLOPHOSPHAMIDE | B-CELL DEPLETION | RHEUMATOLOGY | SLE | TERM EFFICACY | PHASE II/III | THERAPY | PREDICTORS | ANTI-CD20 | LONGITUDINAL ANALYSIS | REMISSION | Outcome Assessment (Health Care) | Humans | Lupus Erythematosus, Systemic - drug therapy | Antirheumatic Agents - adverse effects | Treatment Outcome | Antibodies, Monoclonal, Murine-Derived - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antirheumatic Agents - therapeutic use | Lupus | Care and treatment | Analysis
Rheumatology | Rituximab | Systematic review | Systemic lupus erythematosus | CYCLOPHOSPHAMIDE | B-CELL DEPLETION | RHEUMATOLOGY | SLE | TERM EFFICACY | PHASE II/III | THERAPY | PREDICTORS | ANTI-CD20 | LONGITUDINAL ANALYSIS | REMISSION | Outcome Assessment (Health Care) | Humans | Lupus Erythematosus, Systemic - drug therapy | Antirheumatic Agents - adverse effects | Treatment Outcome | Antibodies, Monoclonal, Murine-Derived - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antirheumatic Agents - therapeutic use | Lupus | Care and treatment | Analysis
Journal Article
Rheumatology International, ISSN 0172-8172, 11/2017, Volume 37, Issue 11, pp. 1853 - 1861
The present study was undertaken to assess mortality, causes of death, and associated prognostic factors in a large cohort of patients diagnosed with...
Idiopathic inflammatory myositis | Prognosis | Medicine & Public Health | Overlap myositis | Survival | Rheumatology | CRITERIA | DERMATOMYOSITIS | LONG-TERM SURVIVAL | POLYMYOSITIS | CLASSIFICATION | LABORATORY FEATURES | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | INTERSTITIAL LUNG-DISEASE | MYOPATHIES | PREDICTIVE FACTORS | Humans | Middle Aged | Myositis - mortality | Adult | Female | Male | Aged | Retrospective Studies | Cause of Death | Myositis | Respiratory tract diseases | Health aspects | Analysis | Mortality | Medical prognosis
Idiopathic inflammatory myositis | Prognosis | Medicine & Public Health | Overlap myositis | Survival | Rheumatology | CRITERIA | DERMATOMYOSITIS | LONG-TERM SURVIVAL | POLYMYOSITIS | CLASSIFICATION | LABORATORY FEATURES | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | INTERSTITIAL LUNG-DISEASE | MYOPATHIES | PREDICTIVE FACTORS | Humans | Middle Aged | Myositis - mortality | Adult | Female | Male | Aged | Retrospective Studies | Cause of Death | Myositis | Respiratory tract diseases | Health aspects | Analysis | Mortality | Medical prognosis
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2016, Volume 46, Issue 5, pp. 569 - 583
Abstract Objectives To evaluate the association between smoking and clinical parameters and structural damage in axial spondyloarthritis (axSpA). Methods We...
Rheumatology | BASDAI | Disease activity | ASQoL | mSASSS | Systematic review | radiographic progression | Euro-QoL | BASRI | HAQ-S | Spondyloarthritis | BASMI | Tobacco | BASFI | quality of life | Ankylosing spondylitis | ASDAS | Smoking | RHEUMATOID-ARTHRITIS | FUNCTIONAL ABILITY | LUPUS-ERYTHEMATOSUS | SPINAL MOBILITY | ANKYLOSING-SPONDYLITIS PATIENTS | BASEL | QUALITY-OF-LIFE | RISK-FACTORS | RHEUMATOLOGY | SOCIETY CLASSIFICATION CRITERIA | DISEASE-ACTIVITY | CIGARETTE-SMOKING | Severity of Illness Index | Prospective Studies | Cross-Sectional Studies | Smoking - epidemiology | Humans | Female | Male | Spondylitis, Ankylosing - physiopathology | Spondylitis, Ankylosing - pathology | Case-Control Studies | Disease Progression | Medicine, Experimental | Medical research | Care and treatment
Rheumatology | BASDAI | Disease activity | ASQoL | mSASSS | Systematic review | radiographic progression | Euro-QoL | BASRI | HAQ-S | Spondyloarthritis | BASMI | Tobacco | BASFI | quality of life | Ankylosing spondylitis | ASDAS | Smoking | RHEUMATOID-ARTHRITIS | FUNCTIONAL ABILITY | LUPUS-ERYTHEMATOSUS | SPINAL MOBILITY | ANKYLOSING-SPONDYLITIS PATIENTS | BASEL | QUALITY-OF-LIFE | RISK-FACTORS | RHEUMATOLOGY | SOCIETY CLASSIFICATION CRITERIA | DISEASE-ACTIVITY | CIGARETTE-SMOKING | Severity of Illness Index | Prospective Studies | Cross-Sectional Studies | Smoking - epidemiology | Humans | Female | Male | Spondylitis, Ankylosing - physiopathology | Spondylitis, Ankylosing - pathology | Case-Control Studies | Disease Progression | Medicine, Experimental | Medical research | Care and treatment
Journal Article
Rheumatology International, ISSN 0172-8172, 1/2019, Volume 39, Issue 1, pp. 47 - 58
The aim of this study is to compare the efficacy and safety of biological therapy with cyclosporin A (CsA), azathioprine (AZA), or placebo in uveitis flares...
Medicine & Public Health | Behçet’s disease | Rheumatology | Uveitis | Systematic literature review | Biologic therapy
Medicine & Public Health | Behçet’s disease | Rheumatology | Uveitis | Systematic literature review | Biologic therapy
Journal Article
RHEUMATOLOGY INTERNATIONAL, ISSN 0172-8172, 01/2019, Volume 39, Issue 1, pp. 47 - 58
The aim of this study is to compare the efficacy and safety of biological therapy with cyclosporin A (CsA), azathioprine (AZA), or placebo in uveitis flares...
REFRACTORY UVEITIS | MULTICENTER | ADALIMUMAB | AZATHIOPRINE | Behcet's disease | RHEUMATOLOGY | OCULAR COMPLICATIONS | INTERFERON ALPHA-2A | Uveitis | INFLIXIMAB | CORTICOSTEROIDS | Systematic literature review | Biologic therapy | CYCLOSPORINE
REFRACTORY UVEITIS | MULTICENTER | ADALIMUMAB | AZATHIOPRINE | Behcet's disease | RHEUMATOLOGY | OCULAR COMPLICATIONS | INTERFERON ALPHA-2A | Uveitis | INFLIXIMAB | CORTICOSTEROIDS | Systematic literature review | Biologic therapy | CYCLOSPORINE
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2017, Volume 11, Issue 3, pp. 749 - 756.e3
Background Plasma concentrations of lipoprotein (a) (Lp(a)), a lipoprotein with atherogenic and thrombogenic properties, have a strong genetic basis, although...
Cardiovascular | Cardiovascular disease | Lipoprotein(a) | Tocilizumab | Rheumatoid arthritis | Biologics | VASCULAR-DISEASE | IMPACT | LIPID PROFILE | INFLAMMATION | PREDICTORS | SERUM-LEVELS | PHARMACOLOGY & PHARMACY | GENETIC RISK-FACTOR | ASSOCIATION | Arthritis, Rheumatoid - therapy | Biological Therapy | Cross-Sectional Studies | Arthritis, Rheumatoid - blood | Humans | Middle Aged | Adult | Female | Male | Risk | Lipoprotein(a) - blood | Proteolipids | Care and treatment | Lipoproteins | Physiological aspects | Research | Blood lipoproteins
Cardiovascular | Cardiovascular disease | Lipoprotein(a) | Tocilizumab | Rheumatoid arthritis | Biologics | VASCULAR-DISEASE | IMPACT | LIPID PROFILE | INFLAMMATION | PREDICTORS | SERUM-LEVELS | PHARMACOLOGY & PHARMACY | GENETIC RISK-FACTOR | ASSOCIATION | Arthritis, Rheumatoid - therapy | Biological Therapy | Cross-Sectional Studies | Arthritis, Rheumatoid - blood | Humans | Middle Aged | Adult | Female | Male | Risk | Lipoprotein(a) - blood | Proteolipids | Care and treatment | Lipoproteins | Physiological aspects | Research | Blood lipoproteins
Journal Article
The Journal of Immunology, ISSN 0022-1767, 12/2009, Volume 183, Issue 12, pp. 8268 - 8279
We previously described that fibroblast-like cells from the synovium of rheumatoid arthritis patients (RASFib) constitutively express intracellular and surface...
TOLL-LIKE | IN-VITRO | ACTIVATION | DENDRITIC CELLS | MEDIATED SUPPRESSION | REG-CELLS | RECEPTOR | PERIPHERAL-BLOOD | GROWTH-FACTOR | IMMUNOLOGY | FOXP3 | Interleukin-15 - physiology | T-Lymphocytes, Regulatory - metabolism | Coculture Techniques | Humans | Middle Aged | Synovial Membrane - immunology | Synovial Membrane - pathology | Male | CD4-Positive T-Lymphocytes - pathology | Interleukin-15 - biosynthesis | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Young Adult | Arthritis, Rheumatoid - metabolism | Lymphocyte Activation - immunology | Inflammation Mediators - metabolism | Aged, 80 and over | Adult | Female | Osteoarthritis - pathology | Inflammation Mediators - physiology | Fibroblasts - metabolism | Gene Expression Regulation - immunology | Osteoarthritis - immunology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Osteoarthritis - metabolism | Fibroblasts - pathology | Synovial Membrane - metabolism | Arthritis, Rheumatoid - pathology | Interleukin-15 - genetics | Up-Regulation - immunology | Down-Regulation - immunology | Fibroblasts - immunology | Aged | Arthritis, Rheumatoid - immunology
TOLL-LIKE | IN-VITRO | ACTIVATION | DENDRITIC CELLS | MEDIATED SUPPRESSION | REG-CELLS | RECEPTOR | PERIPHERAL-BLOOD | GROWTH-FACTOR | IMMUNOLOGY | FOXP3 | Interleukin-15 - physiology | T-Lymphocytes, Regulatory - metabolism | Coculture Techniques | Humans | Middle Aged | Synovial Membrane - immunology | Synovial Membrane - pathology | Male | CD4-Positive T-Lymphocytes - pathology | Interleukin-15 - biosynthesis | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Young Adult | Arthritis, Rheumatoid - metabolism | Lymphocyte Activation - immunology | Inflammation Mediators - metabolism | Aged, 80 and over | Adult | Female | Osteoarthritis - pathology | Inflammation Mediators - physiology | Fibroblasts - metabolism | Gene Expression Regulation - immunology | Osteoarthritis - immunology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Osteoarthritis - metabolism | Fibroblasts - pathology | Synovial Membrane - metabolism | Arthritis, Rheumatoid - pathology | Interleukin-15 - genetics | Up-Regulation - immunology | Down-Regulation - immunology | Fibroblasts - immunology | Aged | Arthritis, Rheumatoid - immunology
Journal Article